Logo

Sankyo Pharma to Help Outfit U of Buffalo s Pharmacy School With PGx Technologies

Apr 15, 2004

NEW YORK, April 15 (GenomeWeb News) - Part of a $100,000 grant from Japanese drug maker Sankyo Pharma will go to help the University of Buffalo's School of Pharmacy and Pharmaceutical Sciences to buy "new analytical equipment" for pharmacogenomics research, according to a local media report.

 

The rest of the money from the Edison, N.J.-based division of Sankyo Pharma will help pay for teaching and training at the pharmaceutical department, the Buffalo Reporter said.

 

Daniel Salazar, senior director of clinical pharmacology and pharmacokinetics for Sankyo, helped organize the deal. He is a graduate of the University of Buffalo School of Pharmacy.

Breaking News
The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.